Jackson, Sarah S.Pfeiffer, RuthGabbi, ChiaraAnderson, LesleyGadalla, Shahinaz M.Koshiol, Jill2022-10-032022-10-032022-02Jackson, S S, Pfeiffer, R, Gabbi, C, Anderson, L, Gadalla, S M & Koshiol, J 2022, 'Menopausal hormone therapy and risk of biliary tract cancers', Hepatology, vol. 75, no. 2, pp. 309-321. https://doi.org/10.1002/hep.321980270-9139ORCID: /0000-0002-1000-3649/work/110275538https://hdl.handle.net/2164/19271Funding: Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in the conduct of this research.13478739290333engSDG 3 - Good Health and Well-beingMenopausal hormone therapybiliary tract cancergallbladder cancercholangiocarcinomaSuppositoriesProgestins/therapeutic useCholangiocarcinoma/epidemiologyHumansMenopauseMiddle AgedCommon Bile Duct Neoplasms/epidemiologyAmpulla of VaterCase-Control StudiesHormone Replacement TherapyIncidenceGallbladder Neoplasms/epidemiologyProgesterone/therapeutic useAged, 80 and overEstrogens/therapeutic useFemaleAdministration, OralRisk FactorsUnited Kingdom/epidemiologyAgedAdministration, TopicalDrug CombinationsNeoplasms, Complex and Mixed/epidemiologyCHOLANGIOCARCINOMAHUMAN FEMALEPREGNANCYREPLACEMENTWOMENGALLBLADDER FUNCTIONDISEASEESTROGENREPRODUCTIVE FACTORSEPIDEMIOLOGYR MedicineHepatologyRJournal article10.1002/hep.32198http://www.scopus.com/inward/record.url?scp=85123314536&partnerID=8YFLogxK752